FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

5600611000001104: Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22870901000001110 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22871001000001118 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Is pack of Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has active ingredient Lisinopril false Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has VMP Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has specific active ingredient Lisinopril true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zestoretic 20 tablets (PI) (Dowelhurst Ltd) 14 tablet Is a True Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 14 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start